India’s offer comes in the backdrop of the US administration’s stated desire to sharply reduce local drug prices, and gains ...

TWN calls for urgent need of stronger scrutiny in granting patents to avoid evergreening: Our Bureau, New Delhi Tuesday, June 3, 2025, 08:00 Hrs [IST] Third World Network (TWN), a ...

India has offered to supply complex generics at just 20–25 percent of the branded drug prices for the first three years after ...

Pharmaceutical companies also use tactics such as evergreening, where they make minor changes to extend patent lives to prolong exclusivity and high prices. A generic drug is similar to a branded ...

and broader patentability rules that support evergreening practices. But things may change now. “Trump’s MFN pricing policy should be a wake-up call. As pharmaceutical companies face tighter ...

Trump's MFN (most-favoured nation) pricing policy should be a wake-up call, as pharmaceutical companies face tighter ... broader patentability criteria, and evergreening practices.

Discussion around international reference pricing (IRP) is intensifying as policymakers search for ways to address persistently high prescription drug costs in the United States. With news of the ...

This decision is crucial for India-US trade negotiations, as tariffs imposed under Trump 2025 executive order remain paused ...

The undertaking to Delhi HC follows a patent infringement plea filed by the Danish drugmaker against Dr Reddy’s Laboratories ...

Generic drugs are cost-effective alternatives to branded medications, offering the same quality, safety, and efficacy, driving global healthcare accessibility. The US generic drug market grows as 42% ...